NEW YORK (GenomeWeb News) – Cepheid today said that Canadian regulatory authorities have cleared for marketing the firm’s molecular diagnostic assay for methicillin-resistant Staphylococcus aureus and Staphylococcus aureus in skin and soft tissue infections.
 
The Xpert MRSA/SA SSTI test runs on Cepheid’s GeneXpert System and can provide test results in less than an hour. The firm noted that its test is the first molecular SSTI diagnostic for MRSA and SA to be cleared in Canada.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.